Report Categories
View AllRecent Articles
View All
JPMorgan Chase JPM Treasury Selloff Accelerates on Hawkish Fed Dissent Spurring 2027 Rate Hike Wagers
Merck Co MRK Upgraded 2026 Guidance and HIV Drug Approval Reinforce But Do Not Reshape LongTerm Investment Thesis
The organic vs inorganic growth story at GridAI Technologies GRDX GridAI Technologies Posts 808 Negative EPS Miss
Lear Corporation LEA EPS beats by 89 but shares fall 166 as investors focus on flat revenue
Analysts View Constellation Brands as Potential Growth Play Amid Beer Strength
Samir Arora Refutes Claims That SIPs Are Driving Rupee Weakness
Intuit to Cut 17 of Workforce Amid AI Focus Shares Sink 42 in 2026
Indian Corporate Balance Sheets Show Maturity as Interest Coverage Ratios Strengthen
Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Finds
Government to Offload Up to 2 Stake in Coal India via OFS Floor Price Set at Rs 412
Playtika Q1 2026 Earnings EPS Misses Estimates by 518 as Stock Declines
MDRR Q2 2021 Earnings BetterthanExpected Loss as Company Navigates Recovery
Intellicheck IDN Q1 2026 Earnings EPS Surges Past Estimates with 974 Beat
Okta Q1 2026 Earnings EPS Beat Drives Positive Market Reaction
BTQ Q1 2026 Earnings EPS Misses Estimates Sharply as Company Continues Investment Phase
LOAN Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines
Broadstone Net Lease BNL Hovers Near Support Amid Low Volatility
Pinnacle Financial Partners PNFP Holds Steady Near 98 as Market Awaits Catalysts
Evommune Inc EVMN Slides 146 Amid Cautious Sector Tone Support at 2185 in Focus
Huron Consulting Group HURN Advances 14 as It Approaches Key Resistance Level
American Shared Hospital Services AMS Holds Steady at 135 as Key Levels Define Trading Range
External Links
Silicon Valley Turns to Boring Businesses AI and Dealmaking Reshape Unsexy Industries
Insight Molecular Diagnostics Inc IMDX Q1 2026 Earnings EPS Surprises to the Upside During PreRevenue Phase
Polyrizon Ltd PLRZ Soars Over 20 Key Levels and Potential Scenarios
MZTI The registers 66 percent Q1 2026 EPS miss shares climb 214 percent on positive investor sentiment
Amgen Inc AMGN Joins FDA RealTime Clinical Trial Pilot as Peer Pharma Pipeline Moves Signal Sector Growth Trajectory
How Olin Corporation OLN is solving the problems its peers cannot Selloff Intensifies 20260508
Why EuroDry EDRY could deliver where others fall short 384 20260503
How Bone Bio BBLG translates market opportunities into growth 301 20260508
ASTH Astrana posts 11 percent Q4 2025 EPS beat shares rise modestly after earnings release
The market opportunity Perrigo PRGO is chasing Trend Weakens 20260508